Skip to main content

Premaitha Launch Non-Invasive Pre-natal Screening Test

Premaitha Launch Non-Invasive Pre-natal Screening Test

Pregnant women in the North West can access a new non-invasive pre-natal screening test (NIPT) for Down’s syndrome from today. This follows a deal between Manchester-based Premaitha Health – developer of the IONA test – and private ultrasound and pregnancy screening clinic group This Is My Ltd.

The specific advantage of the IONA test is that pregnant women in the UK can now receive the information they need to make informed decisions in a much shorter timeframe, thereby reducing anxiety. The blood sample can be analysed in local UK laboratories rather than having to be shipped to the US or China. As a result, the waiting time from blood sample to result is only five days, compared to up to two weeks for samples sent abroad.

Managing director of This Is My Judith Pilling said: “This agreement establishes This is My as one of the first private companies in the UK to offer Premaitha’s ground-breaking IONA test. We are very pleased to partner with another UK company to deliver what we consider to be the gold-standard in non-invasive prenatal screening to our clients.”

See article in full at TheBusinessDesk.com.